ADVERTISEMENT
Poster
P098
Anti-TNF Biologic Therapy Does Not Increase Postoperative Morbidity in Pediatric Crohn`s Patients
BACKGROUND: Limited knowledge exists as to what impact preoperative biologic therapy has on post-operative complications in pediatric patients undergoing abdominal surgery for Crohn’s disease (CD). Therefore, we sought to determine the 30-day postoperative infectious complication rate among pediatric CD patients who received biologic therapy within 12 weeks of an abdominal operation. METHODS: A retrospective chart review was performed on pediatric (
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Stay in the Know
Rheumatology & Arthritis Newsletter
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Popular Articles
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement